THE EFFECT OF MICRONUTRIENT DEFICIENCY ON THE COURSE OF MYASTHENIA GRAVIS: ETIOPATHOGENESIS AND POSSIBLE SOLUTIONS

Authors

  • Xodjiyeva Dilbar Tadjievna Bukhara State Medical Institute
  • Shukrulloeva Nodirabegim Akbarovna Bukhara State Medical Institute

Keywords:

Myasthenia gravis, trace elements, deficiency, magnesium, zinc, selenium, autoimmune disease

Abstract

The article is devoted to the study of the effect of micronutrient deficiency on the course of myasthenia gravis, an autoimmune disease characterized by muscle weakness. Key trace elements such as magnesium, zinc and selenium, which play an important role in neuromuscular transmission and maintenance of the immune response, are considered. The etiopathogenesis of myasthenia gravis is associated with a malfunction of acetylcholine receptors, but a lack of essential trace elements can worsen symptoms, increasing weakness and reducing the overall body's resistance to stress.

References

Binks S., Vincent A., Palace J. Myasthenia gravis: a clinical-immunological update //Journal of neurology. - 2016. – vol. 263. – pp. 826-834.

Grob D. et al. Lifetime course of myasthenia gravis //Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine. – 2008. – vol. 37. – No. 2. – pp. 141-149.

Matuyi t. Myasthenia gravis: clinical, epidemiological, immunological features of myasthenia gravis and methods of therapy //Journal of Humanities and Natural Sciences. – p. 53.

Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America et al. Myasthenia gravis: recommendations for clinical research standards //Neurology. – 2000. – Vol. 55. – No. 1. – pp. 16-23.

Alekseeva T. M., Kosachev V. D., Halmurzina A. N. Myasthenia gravis in the elderly: features of the clinical picture of the onset of the disease //Health–the basis of human potential: problems and solutions. – 2016. – vol. 11. – No. 2. – pp. 499-500.

Asenova A., Bozhinova V., Shokova A. Present for two decays with juvenile myasthenia gravis and myopathen syndrome //Pediatria. – 2017. – Vol. 57. – No. 4.

Jabbarova N., Khodzhieva D. MYASTHENIA KASALLIGINING ETIOLOGY of PATHOGENESIS, TARKALISHI //Eurasian Journal of Medical and Natural Sciences. – 2023. – Vol. 3. – No. 11. – pp. 178-184.

Drozd O. A., Efremov V. V., Dudarev I. V. Experience in the use of oxidative therapy in the complex treatment of myasthenia gravis in the pathology of miscarriage //The chief physician of the South of Russia. – 2013. – №. 4 (35). – Pp. 29-31.

Rachmanina O. A., Levitina E. V., Dzhumaeva G. Sh. MYASTHENIA GRAVIS IN CHILDHOOD: RARE CLINICAL COMBINATIONS //XXI DAVIDENKOV READINGS. – 2019. – pp. 274-276.

Romanova T. V. Myasthenia gravis with late onset of the disease //K 49 Clinical and fundamental aspects of gerontology/ed. GP Kotelnikova, BUT Zakharova,-Samara: Samara State Medical University. Univ., 2015.-399 p. – 2015. – p. 319.

Ruban V. V., Zeulina E. E. The case of successful intensive therapy of an early postoperative complication in a patient after surgery: thymectomy, subtotal resection of the thyroid gland //Bulletin of medical Internet conferences. – Limited Liability Company "Science and Innovation", 2014. – Vol. 4. – No. 4. – p. 343.

Sanadze A. G., Gilvanova O. V. Myasthenia gravis and muscular atrophy //Journal of Neurology and Psychiatry named after CC Korsakov. - 2021. – vol. 121. – No. 2. – pp. 79-87.

Sachenko V. V. et al. Generalized myasthenia gravis associated with thymus neoplasm: clinical case description and literature data. – 2016.

Skvortsov M. B., Smolin A. I. Myasthenia gravis. Surgical treatment and its effectiveness //Acta Biomedica Scientifica. – 2012. – №. 4-1 (86). – Pp. 93-100.

Skripnichenko I. D. Features of the clinic of the ocular form of myasthenia gravis (part 1) //Ophthalmology. Eastern Europe. – 2015. – №. 2. – Pp. 90-96.

Smeyanovich S. V., Vazyuro A.V. Twice seronegative myasthenia gravis in young people. Etiopathogenetic characteristics based on comparison of immunologically heterogeneous groups of myasthenia gravis //Electronic scientific journal. – 2017. – p. 5.

Smolin A. I., Okladnikov V. I., Skvortsov M. B. Neurological assessment of long-term results of thymectomy surgery in the treatment of myasthenia gravis //Baikal Medical Journal. – 2011. – Vol. 106. – No. 7. – pp. 12-14.

Sokolova V. I. et al. SEVERE MYASTHENIA GRAVIS: CHRONIC OBSTRUCTIVE BRONCHITIS. CLINICAL PICTURE AND COURSE //Allergology and immunology. - 2016. – Vol. 17. – No. 1. – pp. 36-37.

Usenova N. Sh., Kinderbaeva N. K., Akhmetov A. B. Myasthenia gravis: private diagnostic errors //Bulletin of the Kyrgyz State Medical Academy named after IK Akhunbayev. - 2010. – No. 2. – pp. 50-52.

Chemordakov I. A., Kutashov V. A. Modern view on the clinic and diagnosis of myasthenia gravis //A young scientist. – 2015. – №. 19. – pp. 311-313.

Chukhlovina M. L., Shabalov N. P., Tsinzerling N. V. Features of pathogenesis, clinic and diagnosis of myasthenia gravis in childhood //Pediatrics. The journal named after G. Speransky. – 2006. – Vol. 85. – No. 3. – pp. 90-94.

Published

2024-10-07

How to Cite

Tadjievna, X. D., & Akbarovna, S. N. (2024). THE EFFECT OF MICRONUTRIENT DEFICIENCY ON THE COURSE OF MYASTHENIA GRAVIS: ETIOPATHOGENESIS AND POSSIBLE SOLUTIONS. International Journal of Cognitive Neuroscience and Psychology, 2(10), 1–4. Retrieved from https://medicaljournals.eu/index.php/IJCNP/article/view/1004